Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Hair loss was found in 37.4% of surveyed rural high-school students in Eskisehir, Turkey, affecting their quality of life, especially in general health and mental well-being.

Acupressure improves quality of life in PCOS patients.

Over half of alopecia areata patients in Tunisia experience depression, highlighting the need for psychological support.

Taking a probiotic supplement twice a day improved hair growth, skin hydration, and metabolic health in adults at risk of metabolic syndrome.

Women with PCOS often have depression and anxiety, so they should be checked for these issues.

Low levels of BDNF and vitamin D are linked to higher depression in alopecia areata and vitiligo patients.

High homocysteine levels in lupus may increase inflammation and cardiovascular risk.

Personality traits significantly affect the onset, progression, and psychological impact of alopecia areata.

The document lists various dermatology topics, treatments, and diagnostic methods.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.

Oxidative stress may play a role in alopecia areata, but depression and suicide risk are similar to healthy peers.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Low-Level Light Therapy improves quality of life more for women than men with hair loss.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Traditional and complementary medicine may help with skin conditions, but more high-quality research is needed.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Caregivers of chronic skin disease patients face significant burdens that harm their quality of life.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Allergens show specific patterns related to season, gender, and age, which can help in developing allergy avoidance plans.

Psychological interventions can improve mental health and quality of life in people with alopecia.